Cancer blunder hits 500 patients of Sydney hospital
More than 500 patients undergoing cancer mutation testing have been affected by a blunder that’s led to at least one ‘adverse clinical health outcome’.
More than 500 patients undergoing cancer mutation testing have been affected by a blunder that’s led to at least one ‘adverse clinical health outcome’.
There’s one big thing missing in our national conversation about health – individual responsibility.
Australia’s largest medicinal cannabis company, Montu, convenes new working group to set principles for telehealth sector, appointing a well-known former health minister as its chair.
The heads of Australia’s medical colleges are warning our public health systems face a dire future of chronic understaffing, unmanageable workloads and critical threats to patient safety unless bureaucratic overreach is overhauled.
It should be easier to commercialise Australian medical research, a key industry figure says.
Labor’s centrepiece Medicare policy promising most patients will be able to see a doctor for free has been discredited as a ‘utopian vision’.
With a hug and a few words, a treasured friend has prompted me into action. Hopefully he does the same for you.
Almost half of all Australians at risk of heart valve disease have never heard of it. A pioneer in its treatment is calling for vigilance.
With PSA tests for prostate cancer offering limited accuracy, could a new urine test be a diagnosis gamechanger?
Australia wants to be the first country in the world to virtually eliminate cervical cancer. New data shows a policy change made a few years ago could help get us there.
The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, providing treatment for those with ‘little hope’.
You might consider it peculiar or even out of line to see an article connecting climate change and environmental pollution with health by a general practitioner, but GPs can no longer separate environmental conditions and human health.
Lorna Hawkey, 84, has spent almost 30 years fighting blood cancer. Valuing independence above all else, she praised a newly subsidised at-home treatment.
Specialist doctors want more transparency over how contracts between health funds and private hospitals are overriding their choices for care, while patients are in the dark.
Cracks in the public health systems are bleedingly obvious, and can no longer be ignored.
Deborah Yates was the kind of doctor who lived to serve in public hospitals. But not any more. She is not alone in turning her back on what she says is a broken system.
In the ongoing search for a reliable male contraceptive, the trial of a new sperm-blocking “hydrogel” has shown early promise.
Shrouded in controversy, tightly regulated but the science far from settled: inside the veiled world of Australia’s legal, cutting-edge, MDMA-led therapy.
A newly subsidised immunotherapy for multiple myeloma presents the first chance for some patients to access such treatment.
Psychedelic medicine is being pushed further into the mainstream with the DVA to fund the therapies for ill veterans, as the TGA weighs up also allowing it for palliative care.
Adelaide talkback radio isn’t the typical setting for an ambush, but it was Health Minister Mark Butler who caught by surprise on Thursday morning when a pair of disgruntled callers phoned in.
Exposure to the bacteria in childhood may be part of the puzzle over why there has been a jump in cancer rates among the young.
It started as a staff uprising, led by an unassuming intensive-care physician, that grew into a statewide probe and fears of a toxic culture gripping a health system.
Hospitals are at risk of being drained of the country’s most talented and skilled doctors with swathes of the medical workforce set to abandon the public sector amid what is being described as a widespread culture of cover-up and payback.
Helping men get over their reluctance to see a doctor is part of a Labor’s new $32m health funding election pledge.
The Albanese government is tight-lipped on the fate of funding allocated for a rare children’s cancer despite lobbying by families and advocates.
Mayne Pharma, which is the target of a $672m foreign takeover bid, appears unperturbed by the likely impact of Donald Trump’s import tariffs on the drug sector.
Meaningful commitments to long-term reform of hospitals and general practice care are what’s needed, not more flashy announcements, says the NSW president of the AMA.
Millions of long-Covid patients continue to struggle with cognitive difficulties.
Whether you need a little bit of help or a lot, there’s likely a solution out there for those with erectile dysfunction. We give you the latest.
Original URL: https://www.theaustralian.com.au/health/medical